Premium
The HSPB8‐BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases
Author(s) -
Seidel K.,
Vinet J.,
den Dunnen W. F. A.,
Brunt E. R.,
Meister M.,
Boncoraglio A.,
Zijlstra M. P.,
Boddeke H. W. G. M.,
Rüb U.,
Kampinga H. H.,
Carra S.
Publication year - 2012
Publication title -
neuropathology and applied neurobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.538
H-Index - 95
eISSN - 1365-2990
pISSN - 0305-1846
DOI - 10.1111/j.1365-2990.2011.01198.x
Subject(s) - downregulation and upregulation , bag3 , protein aggregation , heat shock protein , neuropathology , chaperone (clinical) , microbiology and biotechnology , autophagy , chemistry , biology , neuroscience , pathology , medicine , disease , apoptosis , biochemistry , gene
K. Seidel, J. Vinet, W. F. A. den Dunnen, E. R. Brunt, M. Meister, A. Boncoraglio, M. P. Zijlstra, H. W. G. M. Boddeke, U. Rüb, H. H. Kampinga and S. Carra (2012) Neuropathology and Applied Neurobiology 38, 39–53 The HSPB8‐BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases Aims: HSPB8 is a small heat shock protein that forms a complex with the co‐chaperone BAG3. Overexpression of the HSPB8‐BAG3 complex in cells stimulates autophagy and facilitates the clearance of mutated aggregation‐prone proteins, whose accumulation is a hallmark of many neurodegenerative disorders. HSPB8‐BAG3 could thus play a protective role in protein aggregation diseases and might be specifically upregulated in response to aggregate‐prone protein‐mediated toxicity. Here we analysed HSPB8‐BAG3 expression levels in post‐mortem human brain tissue from patients suffering of the following protein conformation disorders: Alzheimer's disease, Parkinson's disease, Huntington's disease and spinocerebellar ataxia type 3 (SCA3). Methods: Western blotting and immunohistochemistry techniques were used to analyse HSPB8 and BAG3 expression levels in fibroblasts from SCA3 patients and post‐mortem brain tissues, respectively. Results: In all diseases investigated, we observed a strong upregulation of HSPB8 and a moderate upregulation of BAG3 specifically in astrocytes in the cerebral areas affected by neuronal damage and degeneration. Intriguingly, no significant change in the HSPB8‐BAG3 expression levels was observed within neurones, irrespective of their localization or of the presence of proteinaceous aggregates. Conclusions: We propose that the upregulation of HSPB8 and BAG3 may enhance the ability of astrocytes to clear aggregated proteins released from neurones and cellular debris, maintain the local tissue homeostasis and/or participate in the cytoskeletal remodelling that astrocytes undergo during astrogliosis.